International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study
- 260 Downloads
KeywordsOsteoporosis Glucocorticoid Postmenopausal Woman Medical Management Bone Health
The researchers were not specifically funded to do this research. The GLOW study was financed through a grant from Warner Chilcott and Sanofi to the Center for Outcomes Research, University of Massachusetts, Worcester, MA.
Conflicts of interest
Stuart Silverman, Jeffrey Curtis, Kenneth Saag, Julie Flahive, Frederick Anderson, Roland Chapurlat, Christian Roux, JC Netelenbos, Johannes Pfeilschiffer, Nelson Watts, and Juliet Compston declare no conflict of interest. Jonathan Adachi declares that he is a consultant to Actavis, Amgen, Lilly, Merck, and Novartis and is doing clinical trials with Amgen, Lilly, Merck, and Novartis.